Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.
View Top Employees from Evaxion Biotech A/S| Website | https://www.evaxion-biotech.com |
| Employees | 84 (84 on RocketReach) |
| Founded | 2008 |
| Industry | Biotechnology Research, Immunoinformatics, Bioinformatics, Infectious Diseases, Immuno-Oncology, Vaccines, Immunotherapy, Artificial Intelligence, Antigen Discovery, Neo Epitope Discovery |
Looking for a particular Evaxion Biotech A/S employee's phone or email?
Evaxion Biotech A/S Questions
Erik Heegaard is the Chief Medical Officer of Evaxion Biotech A/S.
84 people are employed at Evaxion Biotech A/S.
Top Evaxion Biotech A/S Employees
-
4
-
3
-
2
-
41
Related Companies
